Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Marlow

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BJU International|August 15, 2009
DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programmeSumit Isharwal, Danil V Makarov, H Ballentine Carter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 31, 2006
Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in GhanaClive Shiff, Robert Veltri, Jean Naples, et al.
Urology|October 31, 2006
Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancerRobert W Veltri, Masood A Khan, Cameron Marlow, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Molecular Cancer Therapeutics|April 18, 2009
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivoMadeleine S Q Kortenhorst, Sumit Isharwal, Paul J van Diest, et al.
Research Square|April 3, 2026
CLOCK is an Epigenetic Integrator of Circadian Rhythm and T Cell ImmunityKhashayarsha Khazaie, Shirin Eyvazi, Abu Osman, et al.
Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BJU International|August 15, 2009
DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programmeSumit Isharwal, Danil V Makarov, H Ballentine Carter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 31, 2006
Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in GhanaClive Shiff, Robert Veltri, Jean Naples, et al.
Urology|October 31, 2006
Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancerRobert W Veltri, Masood A Khan, Cameron Marlow, et al.
The Prostate|December 19, 2007
Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intentDanil V Makarov, Cameron Marlow, Jonathan I Epstein, et al.
Molecular Cancer Therapeutics|April 18, 2009
Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivoMadeleine S Q Kortenhorst, Sumit Isharwal, Paul J van Diest, et al.
Research Square|April 3, 2026
CLOCK is an Epigenetic Integrator of Circadian Rhythm and T Cell ImmunityKhashayarsha Khazaie, Shirin Eyvazi, Abu Osman, et al.
Urology|January 11, 2011
ProPSA and diagnostic biopsy tissue DNA content combination improves accuracy to predict need for prostate cancer treatment among men enrolled in an active surveillance programSumit Isharwal, Danil V Makarov, Lori J Sokoll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancerDanil V Makarov, Sumit Isharwal, Lori J Sokoll, et al.
Pageof 2